It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Since its discovery in 2019, multiple variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) have been identified. This study investigates virus spread and associated pathology in the upper and lower respiratory tracts of Syrian golden hamsters at 4 days post intranasal SARS-CoV-2 Omicron infection, in comparison to infection with variants of concern (VOCs) Gamma and Delta as well as ancestral strain 614 G. Pathological changes in the upper and lower respiratory tract of VOC Omicron infected hamsters are milder than those caused by other investigated strains. VOC Omicron infection causes a mild rhinitis with little involvement of the olfactory epithelium and minimal lesions in the lung, with frequent sparing of the alveolar compartment. Similarly, viral antigen, RNA and infectious virus titers are lower in respiratory tissues of VOC Omicron infected hamsters. These findings demonstrate that the variant has a decreased pathogenicity for the upper and lower respiratory tract of hamsters.
Since the emergence of SARS-CoV-2 several variants of concerns have been identified, with altered disease progression and transmission dynamics. Here, Armando et al. compare virus spread and pathology in the upper and lower respiratory tracts of Syrian golden hamster after 4 days post infection for VOCs Gamma, Delta and Omicron and find milder pathology for Omicron.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Beythien, Georg 1
; Kaiser, Franziska K. 2 ; Allnoch, Lisa 1
; Heydemann, Laura 1
; Rosiak, Malgorzata 1
; Becker, Svenja 1 ; Gonzalez-Hernandez, Mariana 2
; Lamers, Mart M. 3
; Haagmans, Bart L. 3
; Guilfoyle, Kate 4 ; van Amerongen, Geert 4 ; Ciurkiewicz, Malgorzata 1
; Osterhaus, Albert D.M.E. 5 ; Baumgärtner, Wolfgang 1
1 University of Veterinary Medicine, Foundation, Department of Pathology, Hanover, Germany (GRID:grid.412970.9) (ISNI:0000 0001 0126 6191)
2 University of Veterinary Medicine, Foundation, Research Center for Emerging Infections and Zoonoses, Hanover, Germany (GRID:grid.412970.9) (ISNI:0000 0001 0126 6191)
3 Erasmus MC, Department of Viroscience, Rotterdam, Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X)
4 Viroclinics Xplore, Schaijk, Netherlands (GRID:grid.508237.b)
5 University of Veterinary Medicine, Foundation, Research Center for Emerging Infections and Zoonoses, Hanover, Germany (GRID:grid.412970.9) (ISNI:0000 0001 0126 6191); Center of Excellence, University of Veterinary Medicine, Foundation, Global Virus Network, Hanover, Germany (GRID:grid.412970.9) (ISNI:0000 0001 0126 6191)




